These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 16740746)

  • 21. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride.
    Buron N; Micheau O; Cathelin S; Lafontaine PO; Creuzot-Garcher C; Solary E
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4221-30. PubMed ID: 17003409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
    Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
    Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
    Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
    J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
    Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
    Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
    Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
    J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cFLIP regulation of lymphocyte activation and development.
    Budd RC; Yeh WC; Tschopp J
    Nat Rev Immunol; 2006 Mar; 6(3):196-204. PubMed ID: 16498450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of cFLIP(L) in colonic adenocarcinoma.
    Ryu BK; Lee MG; Chi SG; Kim YW; Park JH
    J Pathol; 2001 May; 194(1):15-9. PubMed ID: 11329136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.
    Morales JC; Ruiz-Magaña MJ; Ruiz-Ruiz C
    Mol Immunol; 2007 Apr; 44(10):2587-97. PubMed ID: 17257681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel strategy for preventing human CD8+ cytotoxic T lymphocyte-mediated cytotoxicity against pig endothelial cells by overexpression of pig cellular FLICE-like inhibitory protein (c-FLIP) gene.
    Tanemura M; Saga A; Kawamoto K; Matsuda-Minehata F; Manabe N; Deguchi T; Nishida T; Sawa Y; Ito T
    Transplant Proc; 2006 Dec; 38(10):3315-7. PubMed ID: 17175259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
    Kuo PL
    Life Sci; 2005 Oct; 77(23):2964-76. PubMed ID: 15982670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
    Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
    Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible resistance to Fas-mediated apoptosis in B cells.
    Rothstein TL
    Cell Res; 2000 Dec; 10(4):245-66. PubMed ID: 11191348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participation of FLIP, RIP and Bcl-x(L) in Fas-mediated T-cell death.
    Djerbi M; Malinowski MM; Yagita H; Zhivotovsky B; Grandien A
    Scand J Immunol; 2007 Oct; 66(4):410-21. PubMed ID: 17850585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.